Enhancement of colorectal tumor targeting using a novel biparatopic monoclonal antibody against carcinoembryonic antigen in experimental radioimmunoguided surgery.
Biparatopic CEA, carcinoembryonic antigen (MAb) was newly designed and tested as to whether it enhanced the accuracy of tumor detection by reducing non-specific binding in experimental radioimmunoguided surgery. Biparatopic MAb was prepared by using cross-linking of reduced Fab' fragments from...
Principais autores: | Kim, J, Roh, SA, Koo, K, Ryu, J, Hong, H, Oh, S, Kim, H, Bodmer, W |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2002
|
Registros relacionados
-
Preclinical application of radioimmunoguided surgery using anti-carcinoembryonic antigen biparatopic antibody in the colon cancer.
por: Kim, J, et al.
Publicado em: (2005) -
Applicability of carcinoembryonic antigen-specific monoclonal antibodies to radioimmunoguided surgery for human colorectal carcinoma.
por: Kim, J, et al.
Publicado em: (2000) -
Distribution of carcinoembryonic antigen and biologic behavior in colorectal carcinoma.
por: Kim, J, et al.
Publicado em: (1999) -
Targeted killing of colorectal cell lines and murine adenomas using a monoclonal antibody against membrane bound carcinoembryonic antigen
por: Conaghan, P, et al.
Publicado em: (2006) -
Targeted killing of colorectal cancer cell lines by a humanised IgG1 monoclonal antibody that binds to membrane-bound carcinoembryonic antigen.
por: Conaghan, P, et al.
Publicado em: (2008)